Clinical trials for Chronic Obstructive Pulmonary Disease (COPD) in United States

Leveraging Lung Cancer Screening to Optimize Screening Outcomes and COPD Management: COPD in LCS Registry

Study ID: NCT06974981

Sponsor

Thomas Jefferson University

The ROAM Research Study Therapy (LTOT) Version

Study ID: NCT06810323

Sponsor

University of Virginia

Comprehensive Patient-Centered Home-based Care Coaching for COPD Self-management

Study ID: NCT06634810

Sponsor

Icahn School of Medicine at Mount Sinai

Responses to Live Attenuated Influenza Virus (LAIV) in Chronic Obstructive Pulmonary Disease (COPD)

Study ID: NCT04901455

Sponsor

University of North Carolina, Chapel Hill

Combined Zephyr Valve System With Inter-lobar Fissure Completion for Lung Volume Reduction in Emphysema

Study ID: NCT04801108

Sponsor

Beth Israel Deaconess Medical Center

A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-Obstructive Disease

Study ID: NCT06603246

Sponsor

Genentech, Inc.

Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE)

Study ID: NCT04069312

Sponsor

Johns Hopkins University

CareCOPD - COPD Home Monitoring Study

Study ID: NCT04918095

Sponsor

LABIT LABS LLC

A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)

Study ID: NCT04636814

Sponsor

Chiesi Farmaceutici S.p.A.

Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD)

Study ID: NCT06940154

Sponsor

Connect Biopharm LLC